bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. (BIAF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BIAF · as of Jun 9, 2026
Key Statistics
Explore bioAffinity Technologies, Inc. Data
biaf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
biaf competitorsBIAF
ARTL
CARM
GTBP
LIPO
MNDRStock Performance
Full HistoryAbout bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lun…
what is bioaffinity technologies, inc. · biaf stock overview · bioaffinity technologies, inc. company profile · who is bioaffinity technologies, inc. ceo · biaf NASDAQ · bioaffinity technologies, inc. headquarters · bioaffinity technologies, inc. business segments
About Stock Overview & Key Data
bioAffinity Technologies, Inc. (BIAF) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Sep 1, 2022. As of the latest trading session, BIAF stock price is $1.60, with a market capitalization of $7.3M. The stock has returned -81.40% over the past 12 months and +35.59% year-to-date.
According to 1 Wall Street analysts, the consensus rating for bioAffinity Technologies, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, bioAffinity Technologies, Inc. reported revenue of $6.2M and net income of -$14.9M. For detailed data — including bioAffinity Technologies, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, bioAffinity Technologies, Inc. (BIAF) stock price is $1.60. The stock is traded on NASDAQ under the ticker symbol BIAF. The 52-week range is $0.69 – $13.80.